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Among 62 children with mild malaria, cerebral malaria, or
severe malarial anemia, we analyzed the transcription of dif-
ferent var gene types. There was no difference in parasitemia
level or body temperature between groups. However, a sig-
nificantly different expression pattern was observed in chil-
dren with cerebral malaria, compared with that in patients
in the other 2 groups: children with cerebral malaria had
lower expression of the upsA subtype but higher expression
of the upsB and upsC subtypes. Furthermore, expression of
human genes responsive to tumor necrosis factor and hyp-
oxia correlated with distinct ups types.
Malaria caused by the protozoan parasite Plasmodium falciparum
affects individuals in different ways. Infections can be asymp-
tomatic or can manifest themselves via severe signs and symp-
toms—including severe malarial anemia and cerebral malaria,
both of which very often lead to the death of the patient. In
Africa, where the burden of the disease is highest, severe malaria
is mostly encountered in children of young ages, whereas asymp-
tomatic infection is found in persons of all ages but is predom-
inantly encountered in semi-immune adolescents and adults. The
outcome of an infection is determined by both host and parasite
factors. A main factor of parasite virulence is P. falciparum eryth-
rocyte membrane protein 1 (PfEMP1), which is thought to in-
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teract with several host cell receptors in microvessels of various
organs, causing cytoadherence and consequent tissue damage [1].
Binding to various receptors is mediated by the structural
features of the Duffy binding–like domains (DBLs) or the cys-
tein-rich interdomain regions of PfEMP1. PfEMP1 is encoded
by the var gene family; this family consists of ∼60 genes, only
one of which is expressed at any given time point in the parasite.
var genes can be grouped according to their chromosomal lo-
calization and their 5′ transcribed region into upsA, upsB, or
upsC subtypes. Previous studies have provided evidence that
these subtypes are associated with various disease outcomes.
Two studies, one in Papua New Guinea and one in Tanzania,
compared asymptomatic infections with clinical malaria (mild
or severe) and showed preferential expression of either group
A var genes or group A and B var genes in clinical cases [2,
3]. In another study in Kenya, investigators found no associ-
ation when comparing severe and mild disease [4], whereas in
Mali an association between group A var genes and cerebral
malaria was observed in children [5]. Such conflicting results
may be due to differences in geographic region or to physio-
logical differences among the groups of patients with severe
malaria, who might have a mixture of various, not-well-defined
symptoms; alternatively, the group might simply be too small
in size. In the present study, we compared var gene expression
between children with mild malaria and children with cerebral
malaria or severe anemia, all of whom were comparable with
respect to age, parasitemia level, and body temperature. We also
examined correlations between var gene types and expression
of human genes relevant to the response to tumor necrosis
factor (TNF), hypoxia, and arginine metabolism.
Methods. African children from Gabon aged 6 months to
6 years who presented to the Centre Hoˆspitalier de Libreville
or the Albert Schweitzer Hospital in Lambare´ne´ for malaria
diagnosis were eligible for the study. Children with either ce-
rebral malaria (Blantyre Coma Scale [BCS] score, !3), severe
malarial anemia (hemoglobin level, !5 g/dL), or uncomplicated
malaria were recruited after parental informed consent was ob-
tained. Entry criteria were a temperature of 137C and the pres-
ence of P. falciparum parasitemia, as determined by examination
of thick blood smears. Exclusion criteria were asymptomatic P.
falciparum infection and indications for concurrent diseases. Five
milliliters of peripheral blood was obtained from each child by
health personnel and was transferred into PAXGene RNA tubes
(Qiagen), in accordance with the manufacturer’s instructions.
RNA was extracted using the PAXGene Blood RNA kit (Qiagen),
in accordance with the manufacturer’s instructions. Comple-
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(n p 15) P
Temperature, C 38.1  1.0 38.5  1.0 38.4  1.1 .54
BCS scorea 2  0 5  0 5  0 !.001
Parasitemia level, parasites/mL
Median  absolute deviation 49,200  45,700 26,250  20,738 66,500  58,500 .22
Range 1500–855,000 1500–236,000 3600–300,000
Hemoglobin level, g/dLa 6.8  2.2 3.7  0.6 8.4  2.3 !.001
Age, months 42  22 30  23 39  17 .07
NOTE. Data are means  absolute deviation of the mean, unless otherwise indicated. P values were calculated by Kruskal-
Wallis estimation.
a Blantyre Coma Scale (BCS) score and hemoglobin level were used for classification of groups.
mentary DNA (cDNA) was synthesized using SuperScript II re-
verse transcriptase (Invitrogen).
For differential var group transcriptional analysis, quanti-
tative real-time polymerase chain reaction (PCR) specific for
all 3 var gene groups was performed as described elsewhere
[3], using seryl-tRNA synthetase and fructose-bisphosphate al-
dolase transcripts as endogenous controls. Quantitative real-
time PCR with minor groove binding (MGB) probes was per-
formed using a ABI Prism 7200 sequence detection system
(Applied Biosystems), as described elsewhere [2] with a few
modifications. Briefly, cDNA was synthesized from total RNA,
and a primary PCR with 16 cycles over the var 5′ untranslated
region (UTR)–DBL1a target sequence was performed before
real-time PCR was performed for var groups A, B, and C.
Primers and probes targeting upsA, upsB, and upsC var genes
for the MGB probe assay (upsA probe, upsB probe, and upsC
probe) have been described elsewhere [2]. As an internal control
gene, seryl-tRNA synthetase was used for relative quantification
without prior amplification. Primers and probes were designed
using Primer Express software (version 2.0; Applied Biosys-
tems) and included p90Probe_for (5′-ACCTCAGAACAACCA-
TTATGTGCTT-3′), p90Probe_rev (5′-TGTGCCCCTGCTTC-
TTTTCTAA-3′), and p90Probe (5′-[6-FAM]AGGTTACCAC-
TCAAATACGCTGGATTCTCATCTTG[TAMRA-6-FAM]-3′).
Oligonucleotide primers for amplification of var gene regions




3′); for var group B, 5_UTR (360 bp), 17deg_for* (5′-CTC-
AT[A/T]TATAATTTTA[C/G]AAAATA[A/T]A[A/T]AAAAC-
3′), upsB1_probe (5′-[6FAM]-TCTAACAAAAAAAAAAAAC-
AACAATTAC-MGB-3′), and RT-17.2_rev (5′-TTA[A/T]GG-
GAGTAT[A/T]GT[A/G/T]ATATGGTAGAAT-3′); and for var
group C, 5_UTR (240 bp), RT-5B1.1_for* (5′-AATATTCAT-
ATTCCCACATT[A/G]TCATATAT-3′), upsC_probe (5′-[6FAM]-
ACATATAATACGACTAAGAAAC-MGB-3′), and 5B1.4_rev (5′-
ATTATGTGGTAATATCATGTAATGG-3′). Forward primers
marked with an asterisk (*) were identical in primary and real-
time PCR.
The expression profile of defined human genes was deter-
mined using 2-step Assay-on-Demand gene expression prod-
ucts (Applied Biosystems). After cDNA was synthesized from
total RNA by means of SuperScript II reverse transcriptase
(Invitrogen), 20-mL reactions were prepared. Each reaction con-
sisted of 20 ng of cDNA (1 ng/mL), 1 TaqMan Universal
Master mix, and 1 Assay-on-Demand gene expression mix.
For amplification and proof of the target messenger RNA, we
used the GeneAmp 5700 sequence detection system (Applied
Biosystems) with the following conditions: 10 min at 95C,
followed by 40 cycles of 15 s at 95C and 60 s at 60C. As an
endogenous control, we used hypoxanthine guanine phospho-
ribosyl transferase 1. After normalization, the data, logarith-
mized to base 2, were analyzed by analysis of variance (ANOVA)
and were corrected by the Bonferroni-Dunn method.
After all samples had been subjected to real-time PCR, the
data set was cleaned for subsequent statistical analysis. Data
points were not considered if the melting temperature diverged
11C from the expected value or if the cycle threshold (Ct)
value was 130. Transcript abundance was compared between
clinical groups after normalization to internal controls (yielding
DCt values). On the basis of these values, fold changes were
calculated by the DDCt method. Comparisons were done using
the nonparametric Kruskal-Wallis test; parametric tests were
done using ANOVA, with StatView software (version 7.0; SAS
Institute). Differences with were considered significant.P ! .05
This study was approved by the ethics committees of the
International Foundation for the Albert Schweitzer Hospital in
Lambare´ne´, Gabon, and the Medical Faculty of the University
of Tu¨bingen, Germany.
Results. In total, 62 patients with either cerebral malaria
( ), severe malarial anemia ( ), or mild malarianp 21 np 26
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Figure 1. Relative expression of ups variants in patients with malaria of differing severity and influence on host gene expression. A, Boxplots
showing relative expression in patients with cerebral malaria ( ), severe malarial anemia ( ), or uncomplicated malaria ( ). P valuesnp 21 np 26 np 15
are shown only for significant differences. B, Correlation of expression of upsA, upsB, or upsC with 4 selected human genes encoding for carbonic
anhydrase (CA) 2 and 4, kinesin 20A (KIF20A), and tumor necrosis factor–induced protein 6 (TNFIP6). P values are shown only for significant correlations.
( ) were analyzed. The groups did not differ in age, par-np 15
asitemia level, or body temperature. Groups differed signifi-
cantly in the most important criteria, that is, BCS score and
hemoglobin level (Table 1).
When the relative expression of the 3 var gene groups was
analyzed, a significant difference was observed between children
with cerebral malaria and those with uncomplicated malaria or
severe malarial anemia (Figure 1A). In all patient groups, upsA
was the prominent var gene type; it was most pronounced in
patients with severe malarial anemia or uncomplicated malaria
(Figure 1A). The least expressed variant was the upsB type.
When children with cerebral malaria were compared with chil-
dren with severe malarial anemia or uncomplicated malaria,
highly statistically significant differences were observed in the
expression level of all 3 ups groups. No statistically significant
difference was found in the expression pattern of the 3 variants
between children with severe malarial anemia and those with
uncomplicated malaria.
Among 25 patients, all of whom had malarial anemia, we
correlated RNA levels for a panel of human genes with ups
expression; we focused on 10 genes located in the chromosomal
region 5q31–33 (mainly transcription factors and stimulus-re-
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sponsive genes). This region has been described as being in-
volved in mediating protection against malaria and contains
genes coding for cytokines, receptors belonging to clusters of
differentiation (CD), and TNF-responsive molecules. Several
single-nucleotide polymorphisms in these genes have been de-
scribed as being associated with the outcome of malaria. Other
genes were chosen on the basis of their involvement in arginine
metabolism, because it has been shown that low arginine and
low nitric oxide production are common in severe malaria,
probably as a result of increased arginase production in severe
malaria. Another group of molecules we analyzed were trans-
porters that are involved in metabolite transport and pH reg-
ulation. We observed a positive correlation of kinesin 20A (lo-
cated in 5q31–33), TNF-induced protein 6, and carbonic an-
hydrase 2 and 4 with upsA and the opposite for the same genes
with upsB or upsC (Figure 1B). Other genes were not heavily
influenced by ups expression.
Discussion. In African children, cerebral malaria is one the
most dangerous complications of P. falciparum infection. It has
been hypothesized that the course of a malarial infection is
reflected in similar expression patterns for members of cer-
tain var gene groups associated with anemia and uncomplicat-
ed disease, whereas in the case of cerebral complications the var
gene expression pattern is different.
Our results showing a distinct var gene expression pattern in
patients with cerebral malaria are in accordance with observations
of others [5, 6], who also described an association between de-
fined var genes expression patterns and certain clinical presen-
tations. Discrepancies in the expressed subtypes might be ex-
plained merely by geographical or genetic differences. In Gabon,
a child experiences 1–2 episodes of malaria per year; therefore,
the children enrolled in this study will have had a limited number
of infections. This might explain the high prevalence of the var
upsA types, which in another study have been described as being
associated with the first infections occurring in early life [7]. In
our study, patients with cerebral malaria showed a more even
distribution of ups types; this has also been observed in the
expressed var gene repertoire among patients in another study,
which clearly showed that a greater number of var genes are
transcribed in patients with cerebral malaria, whereas fewer var-
iants are transcribed in patients with severe anemia but at a
higher rate [6].
It is possible that ethnically determined host genetic poly-
morphisms could influence the expression of certain var genes,
and the most prominent receptor involved in cerebral malaria
is intercellular adhesion molecule 1 (ICAM-1) [8]. It has been
shown that polymorphisms in ICAM-1 can influence the like-
lihood that a child might develop cerebral malaria. However,
such polymorphisms can be beneficial [8] or detrimental [9]
depending on the region considered, and it is interesting to
speculate to what degree such host polymorphisms can influ-
ence the expression of var genes. Additional studies conducted
in different regions with different ethnic groups will be nec-
essary to reach definitive conclusions.
We present data indicating that specific PfEMP1 types may
influence the expression of human genes. Interestingly, the dif-
ferent ups variants have antidromic effects on defined genes.
Genes regulated in opposite directions in individuals can be
observed in microarray studies involving patients with malaria
[10], in which individual differences were attributed to cellular
activity. Perhaps this countereffect is also caused by the ex-
pressed var gene type in the particular patient. Two of the genes
regulated in this way encode TNF-responsive proteins. TNF it-
self has been shown to be induced by parasites in a strain-spe-
cific manner [11], so perhaps what we see here is a secondary
effect of TNF secreted by macrophages and monocytes on con-
tact with parasitized erythrocytes expressing variant PfEMP1
molecules. In addition, carbonic anhydrases can contribute to
malarial pathology, since it has been shown that free carbonic
anhydrases of erythrocytic origin can mediate hemorrhagic ret-
inal and cerebral vascular permeability [12]. Furthermore, car-
bonic anhydrases are induced by hypoxia, which is a feature
of malaria [13]. Given that upsA types have been correlated
with increased expression of carbonic anhydrases and associ-
ated with severity of malaria in other studies, part of the pa-
thology may be due to overexpression of these enzymes.
Interaction between parasitized cells and immune cells is
common, and suppressive effects on dendritic cells have been
described [14]. The opposite effect, leading to an overstimu-
lated immune response and subsequently to an aggravation of
malarial symptoms, is also conceivable. That PfEMP1 influ-
ences induction by TNF or hypoxia shows a novel facet of the
interplay between host and parasite. Because there are conflict-
ing results regarding the role played by PfEMP1 in interactions
between immune cells and infected blood cells [15], underlying
mechanisms probably depend on cell type and the expressed
var gene and will be investigated in additional studies.
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